A Cohort of Patients With Possible or Confirmed SARS-CoV-2 (COVID-19)

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

500 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-02-01

Study Completion Date

2022-12-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

SARV-CoV-2 infection was considered pandemic on March 11, 2020. The SARV-CoV-2 epidemic affected France from the beginning of March, spreading in particular from a 4-day large evangelical meeting of 2500 people on February 17 in the city of Mulhouse (North East of France). The Montpellier University Hospital has set up a clinical pathway for people suspected of being infected with SARV-CoV-2 because of signs compatible with pneumonia (screening criteria in France during the study period). This includes an emergency department, an infectious disease department dedicated to the surveillance of infected people requiring hospital treatment, and an intensive care unit for the most severe cases. The diagnosis of infection with SARV-CoV-2 was confirmed in approximately 20% of people initially referred in this special care system.

The main objective of this cohorte is the collection of clinical data and biological samples from care for non-interventional research on the patients with a possible or confirmed SARS-CoV -2 infection, from diagnosis to long-term follow-up.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Caracterisation of COVID-19 Patients Hospitalized in Infectious Disease Department

NCT04779021

Covid19 SARS-CoV Infection

UNKNOWN

Host-pathogen Interactions During SARS-CoV-2 Infection

NCT04376476

Infection, Coronavirus Severe Acute Respiratory Syndrome Coronavirus 2

COMPLETED NA

Analysing the French COVID-19 Epidemic Using a National SARS-CoV-2 RT-PCR Database

NCT04738331

Covid-19 SARS-CoV Infection

UNKNOWN

Longitudinal Follow-up of a Population Cohort in a French City With High SARS-CoV-2 Circulation, in Early 2020 [COVID-19]

NCT04644159

SARS (Severe Acute Respiratory Syndrome) Covid19

COMPLETED

Retrospective and Prospective Cohort of Patients Entering the Multidisciplinary Management of Post-Covid Syndromes

NCT05805566

Post-Covid Syndrome

RECRUITING

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

SARS-CoV-2 COVID-19

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

\- Patients care at the Montpellier University Hospital suspected of a COVID-19 infection

Exclusion Criteria

* Patient opposed to the use of his data for research purposes
* Patient deprived of liberty by judicial decision
* Patient not affiliated to a social security scheme

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes